These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 19172673)
1. Follow-up of intensive glucose control in type 2 diabetes. Cruickshank JM N Engl J Med; 2009 Jan; 360(4):417-8; author reply 418. PubMed ID: 19172673 [No Abstract] [Full Text] [Related]
3. [Which antihypertensive therapy is indicated in type 2 diabetic patients?]. Hauner H Dtsch Med Wochenschr; 2002 Jul; 127(28-29):1543-4. PubMed ID: 12111665 [No Abstract] [Full Text] [Related]
4. [Treatment of hypertension in patients with adult-onset diabetes]. Mykkänen L Duodecim; 1999; 115(10):1147-53. PubMed ID: 11877854 [No Abstract] [Full Text] [Related]
5. [Hypertension and diabetes]. Bouhanick B; Laboureau-Soares Barbosa S; Marre M Arch Mal Coeur Vaiss; 2000 Nov; 93(11 Suppl):1429-34. PubMed ID: 11190292 [TBL] [Abstract][Full Text] [Related]
6. Vascular and renal benefits are additive using intensive blood pressure control and incremental glucose control in type 2 diabetic patients. Cardiovasc J Afr; 2008; 19(5):284-6. PubMed ID: 18997995 [No Abstract] [Full Text] [Related]
7. The choice of antihypertensive therapy in patients with the metabolic syndrome--time to change recommendations? Hilgers KF; Mann JF Nephrol Dial Transplant; 2008 Nov; 23(11):3389-91. PubMed ID: 18687734 [No Abstract] [Full Text] [Related]
9. Management of high blood pressure in diabetes mellitus: lessons from The ADA Recommendation. Waspadji S Acta Med Indones; 2004; 36(1):31-5. PubMed ID: 15673934 [No Abstract] [Full Text] [Related]
10. Beta-blockers, diabetes, and hypoglycemia: risky business? Levinson PD Med Health R I; 2001 Mar; 84(3):81-2. PubMed ID: 11280134 [No Abstract] [Full Text] [Related]
11. [Revised guidelines for antihypertensive treatment. What is relevant for the general practitioner?]. Zidek W MMW Fortschr Med; 2004 Jan; 146(1-2):37-8. PubMed ID: 18437867 [No Abstract] [Full Text] [Related]
12. The impact of antihypertensive therapy in type 2 diabetes. Hansson L Diabetes Obes Metab; 2000 Mar; 2 Suppl 1():S37-41. PubMed ID: 11225758 [No Abstract] [Full Text] [Related]
13. [Beta-blockaders for better or for worth--still a good alternative in hypertension]. Bengtsson C; Sigurdsson JA Lakartidningen; 2009 Jan 28-Feb 3; 106(5):298-9. PubMed ID: 19271463 [No Abstract] [Full Text] [Related]
14. [Effect of enalapril on clinical and metabolic characteristics in patients with non-insulin-dependent diabetes and arterial hypertension]. Novikov VI; Miliagina IV Ter Arkh; 2000; 72(12):63-4. PubMed ID: 11201838 [No Abstract] [Full Text] [Related]
15. Prevention of microalbuminuria in type 2 diabetes: millimeters or milligrams? Glassock RJ J Am Soc Nephrol; 2006 Dec; 17(12):3276-8. PubMed ID: 17108313 [No Abstract] [Full Text] [Related]
16. Rationale and design of the AdRem study: evaluating the effects of blood pressure lowering and intensive glucose control on vascular retinal disorders in patients with type 2 diabetes mellitus. Chaturvedi N; Bilous R; Sjolie AK; Klein R; Contemp Clin Trials; 2007 Nov; 28(6):780. PubMed ID: 17643353 [No Abstract] [Full Text] [Related]
19. Hypertension arm of ADVANCE defines extent of renal protection using perindopril/indapamide in type 2 diabetics. Cardiovasc J Afr; 2008; 19(4):226. PubMed ID: 18776973 [No Abstract] [Full Text] [Related]
20. Role of beta-blockers up for debate. Virk IS Postgrad Med; 2004 Jul; 116(1):8-9; author reply 9. PubMed ID: 15274284 [No Abstract] [Full Text] [Related] [Next] [New Search]